Cash Flow EPS Creative Health Technology Group Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
-7.00
33.00
-24.00
-48.00
-22.00
7.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
22.00
-25.00
-7.00
0.00
18.00
-17.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
23.00
-20.00
-31.00
-40.00
3.00
-12.00
Cash Flow from Investing Activities
-3.00
51.00
-21.00
-2.00
-1.00
0.00
Cash Flow from Financing Activities
-32.00
-13.00
38.00
-25.00
111.00
-1.00
Net Cash Inflow / Outflow
-9.00
15.00
-15.00
-67.00
114.00
-14.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
3.00
-2.00
0.00
0.00
2.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of EPS Creative Health Technology Group Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-7.52
94.6550307499293
-101.00
-107.94%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
22.301
-90.1694420886205
112.00
124.73%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
23.572
-3.0832999429644
26.00
864.51%
Cash Flow from Investing Activities
-3.093
47.7201128351662
-50.00
-106.48%
Cash Flow from Financing Activities
-32.761
-38.5591439226722
6.00
15.04%
Net Cash Inflow / Outflow
-9.197
5.54625251787551
-14.00
-265.82%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
3.085
-0.531416451654087
3.00
680.52%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 215.00% vs 35.78% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
23.57
-20.50
215.00%
Footer loading
